NCI Cancer Bulletin: A Trusted Source for Cancer Research News
NCI Cancer Bulletin: A Trusted Source for Cancer Research News
May 25, 2004 • Volume 1 / Number 21 E-Mail This Document  |  View PDF Version  |  Bulletin Archive/Search  |  Subscribe


Bulletin Home

Featured Article
Lower Breast Cancer Risk With Aspirin Linked to Hormone-Receptor Status

Director's Update
Oncology Nurses

Insurance Coverage for Breast Cancer Screening and Related Services

Cancer Research Highlights
Direct Mailing Colorectal Fecal Kits Increases Screening Rates, Study Finds

Recovery from Stem Cell Transplantation Can Take Years Longer than Expected

Danish Study Links Hodgkin's and MS

FDA Approves Drugs for Prostate Cancer and Myelodysplastic Syndrome

Legislative Update
House Hearings Explore Conflict-of-Interest Issues

Funding Opportunities

Featured Clinical Trial
Skin Cancer Prevention Study

Notes
Phase II of Cancer Quality of Care Measures Project Launched

Workshop to Address Preclinical Cancer Detection Methods

United States Signs Tobacco Control Treaty

Rhoades Joins NCI

CCR Grand Rounds

Guest Commentary by Dr. Patricia A. Grady

Bulletin Archive

Page Options
Print This Page  Print This Page
Print This Document  Print This Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
View/Print PDF  View/Print PDF
Funding Opportunities

Cancer Intervention and Surveillance Modeling Network (CISNET)

RFA-CA-05-018
Letter of Intent Receipt Date: Sept. 14, 2004
Application Receipt Date: Oct. 14, 2004

This RFA is a reissue of RFA-CA-99-013 and RFA-CA-02-010. NCI invites applications to support collaborative research using simulation and other modeling techniques to describe the impact of interventions (i.e., primary prevention, screening, and treatment) in population-based settings in order to ascertain determinants of cancer trends. The primary goals of this research are: (1) To determine the impact of cancer control interventions on observed trends in incidence and/or mortality and (2) To determine whether recommended interventions are having their expected population impact by examining discrepancies between controlled cancer intervention study results and the population experience.

The RFA will use the NIH (U01) award mechanism.

For more information see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=2080

Inquiries: Dr. Eric Feuer, rf41u@nih.gov

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov